Market Performance - The Hong Kong pharmaceutical sector experienced a morning surge followed by a decline, but rebounded again before noon. As of the midday close, the CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index rose by 0.5% [1] - The Hang Seng Stock Connect Innovative Drug Index increased by 0.4%, while the CSI Innovative Drug Industry Index and the CSI Biotechnology Theme Index saw gains of 0.2% and 0.1%, respectively. The CSI 300 Pharmaceutical and Health Index remained close to flat [1] Index Composition - The indices focus on leading companies in the pharmaceutical and health industry, covering segments such as chemical pharmaceuticals, medical services, and medical devices. The CSI 300 Pharmaceutical and Health Index has been tracking since July 2007 [4] - The rolling price-to-earnings (P/E) ratio for the indices indicates varying valuation levels, with some indices showing a P/E ratio of 63.9 times and a valuation percentile of 84.4% [4]
港股医药板块探底回升，关注恒生创新药ETF（159316）、港股通医药ETF（513200）等布局机会
Mei Ri Jing Ji Xin Wen·2025-09-22 06:30